Traws Pharma
(NASDAQ) TRAW
Traws Pharma Financials at a Glance
Market Cap
$13.11M
Revenue (TTM)
$2.96M
Net Income (TTM)
$23.01M
EPS (TTM)
$24.08
P/E Ratio
0.07
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$1.64
Volume
86,178.518
Open
$1.67
Price
$1.64
Volume
86,178.518
Open
$1.67
Previous Close
$1.64
Daily Range
$1.49 - $1.72
52-Week Range
$0.97 - $3.27
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$1.64
Volume
86,178.518
Open
$1.67
Previous Close
$1.64
Daily Range
$1.49 - $1.72
52-Week Range
$0.97 - $3.27
TRAW News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Traws Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
7
CEO
Iain David Dukes, PhD
Website
www.trawspharma.comHeadquarters
Newtown, PA 18940, US
TRAW Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-4%
Net Income Margin
-3%
Return on Equity
7432%
Return on Capital
-1%
Return on Assets
-58%
Earnings Yield
14.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.11M
Shares Outstanding
7.99M
Volume
86.18K
Short Interest
0.00%
Avg. Volume
190.47K
Financials (TTM)
Gross Profit
$214.00K
Operating Income
$49.35M
EBITDA
$166.51M
Operating Cash Flow
$29.79M
Capital Expenditure
$0.00
Free Cash Flow
$29.79M
Cash & ST Invst.
$21.34M
Total Debt
$0.00
Traws Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.73M
+2318.6%
Gross Profit
$2.73M
+2318.6%
Gross Margin
100.00%
N/A
Market Cap
$13.11M
N/A
Market Cap/Employee
$2.18M
N/A
Employees
6
N/A
Net Income
$625.00K
+93.8%
EBITDA
$2.50M
+76.8%
Quarterly Fundamentals
Net Cash
$13.08M
-56.0%
Accounts Receivable
$1.32M
+7682.4%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-58.25%
N/A
Return on Invested Capital
-1.18%
N/A
Free Cash Flow
$5.98M
-33.2%
Operating Cash Flow
$5.98M
-33.2%